High-dose romiplostim accelerates hematologic recovery in patients with aplastic anemia refractory to eltrombopag.

Leukemia

Department of Hematology, Faculty of Medicine, Institute of Medical Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa, Japan.

Published: March 2021

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41375-020-0950-6DOI Listing

Publication Analysis

Top Keywords

high-dose romiplostim
4
romiplostim accelerates
4
accelerates hematologic
4
hematologic recovery
4
recovery patients
4
patients aplastic
4
aplastic anemia
4
anemia refractory
4
refractory eltrombopag
4
high-dose
1

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!